Replies to post #171470 on Biotech Values

[oc631]

Agree as well. BTW do we know the % of prior null responders on GILD results ?

Null responders to interferon isn't a valuable metric since we have entered the world of oral therapy. Without looking, it's quite possible GILD left this data off the PR.

[DewDiligence]

do we know the % of prior null responders in GILD results?

No, and GILD presumably won’t report this detail of ION-2 until the data are presented at a medical conference (probably EASL in Apr 2014).

GILD also didn’t disclose the SVR12 rate for cirrhotics, GT1a, and GT1b.